Premium
The effect of pirenzepine (LS 519), a specific antimuscarinic drug, on cortisol levels in man
Author(s) -
Alagna Sergio,
Masala Antonio,
Satta Andrea,
Faedda Rossana,
Devilla Luisa,
Rassu Sergio,
Rovasio Pier Paolo
Publication year - 1983
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.430030412
Subject(s) - pirenzepine , endocrinology , medicine , muscarinic acetylcholine receptor , drug , basal (medicine) , receptor , pharmacology , insulin
The authors investigated the effect of a single 75‐mg oral dose of pirenzepine, a drug which selectively blocks the muscarinic receptors and does not cross the blood‐brain barrier, on the function of the HPA axis. A significant decrease in basal cortisol values following the administration of the drug was observed in comparison with a placebo test. Moreover, the adrenal response to exogenous adrenocorticotropin (ACTH) administration was unchanged following a 5‐day course of the drug, ruling out direct action of pirenzepine at the adrenal level. These data suggest that cholinergic muscarinic hypothalamic and/or pituitary systems may be involved in the regulation of ACTH‐cortisol secretion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom